[{"NetIncomeLoss_2_Q2_USD":-24190000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":11960354.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":11960354.0,"RestructuringCharges_1_Q2_USD":2046000.0,"RestructuringCharges_2_Q2_USD":6354000.0,"AssetsCurrent_0_Q2_USD":180980000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":5569000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":12000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":10000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":3136000.0,"Depreciation_2_Q2_USD":1837000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":39934000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.0134,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":3671000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":439000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":4.97,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.797,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q2_USD":100000.0,"Depreciation_1_Q2_USD":800000.0,"LeaseAndRentalExpense_2_Q2_USD":2700000.0,"LeaseAndRentalExpense_1_Q2_USD":1400000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":5460000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":10941502.0,"OperatingIncomeLoss_1_Q2_USD":-17000000.0,"OperatingIncomeLoss_2_Q2_USD":-31141000.0,"ImpairmentOfLongLivedAssetsHeldForUse_2_Q2_USD":1202000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":5574000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":19524000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-938000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":5681000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":22463000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.87,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":22835935.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":20334000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":579000.0,"Assets_0_Q2_USD":265383000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":115023000.0,"CommonStockSharesIssued_0_Q2_shares":81059005.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":200000.0,"IncomeTaxesReceivable_0_Q2_USD":5665000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":544000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":943000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":123000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":99936000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":21314000.0,"CommonStockValue_0_Q2_USD":8000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-5665000.0,"AccountsReceivableNetCurrent_0_Q2_USD":1169000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-28000.0,"RestrictedCash_0_Q2_USD":468000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-47000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":246000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":555000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":2591000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":55059000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":4.81,"ResearchAndDevelopmentExpense_1_Q2_USD":11108000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":26936000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2862000.0,"ProceedsFromStockPlans_2_Q2_USD":40000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":153082000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":9673000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-24165000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":555000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":80862621.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":80810211.0,"GeneralAndAdministrativeExpense_1_Q2_USD":9284000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":17103000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":5.82,"MarketableSecuritiesCurrent_0_Q2_USD":100028000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":32596000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":109000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":28000.0,"Liabilities_0_Q2_USD":218767000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":557263000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":30855000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":71103000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":272000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":136000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1245000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-16036000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":100000.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":5665000.0,"InvestmentIncomeInterest_2_Q2_USD":1333000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":71571000.0,"NonoperatingIncomeExpense_1_Q2_USD":385000.0,"NonoperatingIncomeExpense_2_Q2_USD":1286000.0,"AccountsPayableCurrent_0_Q2_USD":1339000.0,"LiabilitiesCurrent_0_Q2_USD":20303000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":5332000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":14995000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":100028000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3015000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-28824000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-3000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_2_Q2_shares":3229427.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3028000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":544000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-16615000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-29855000.0,"Goodwill_0_Q2_USD":8177000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":103000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":470000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.75,"ProceedsFromStockOptionsExercised_2_Q2_USD":83000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":71103000.0,"NetIncomeLoss_1_Q2_USD":-16615000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":21706000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":3369000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":2013000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":65000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":3531000.0,"OperatingLeasePayments_2_Q2_USD":2798000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":8513000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":40000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":91460.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.0045,"SecurityDeposit_0_Q2_USD":500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":3608000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.12,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":18723000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":806000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":579000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":25000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":15119000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":555000.0,"OperatingExpenses_1_Q2_USD":22574000.0,"OperatingExpenses_2_Q2_USD":50665000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":278000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1741000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":36825000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":2024708.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":9000000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3028000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5063000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4539000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":265383000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.91,"PreferredStockValue_0_Q2_USD":null,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":11104000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.14,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":4935000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"InvestmentIncomeInterest_1_Q2_USD":413000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":1056000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-7666000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.3,"ProfitLoss_2_Q2_USD":-24190000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":10204429.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":113683000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":555000.0,"RestrictedCashNoncurrent_0_Q2_USD":468000.0,"CommonStockSharesOutstanding_0_Q2_shares":81059005.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":820000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":11479000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-511094000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":6264788.0,"VariableLeaseCost_1_Q2_USD":300000.0,"VariableLeaseCost_2_Q2_USD":700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":11317276.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":418000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":555000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":114932000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":9000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":161312000.0,"StockholdersEquity_0_Q2_USD":46616000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":753000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.21,"AccruedProfessionalFeesCurrent_0_Q2_USD":3410000.0,"Ticker":"KDNY","CIK":"1435049","name":"ADURO BIOTECH, INC.","OfficialName":"Chinook Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"858364832.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200803"}]